{
    "organizations": [],
    "uuid": "2fb704f3016604e1d8ca857670ed9782e5b8e8d9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-protagonist-therapeutics-reports-q/brief-protagonist-therapeutics-reports-q1-net-loss-per-share-0-36-idUSASC0A12Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Protagonist Therapeutics Reports Q1 Net Loss Per Share $0.36",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Protagonist Therapeutics Inc:\n* PROTAGONIST THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* PROTAGONIST THERAPEUTICS INC - QTRLY NET LOSS PER SHARE $0.36\n* PROTAGONIST THERAPEUTICS INC - QTRLY LICENSE AND COLLABORATION REVENUE - RELATED PARTY $10.8 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:17:00.000+03:00",
    "crawled": "2018-05-10T17:48:20.024+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "protagonist",
        "therapeutic",
        "inc",
        "protagonist",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "protagonist",
        "therapeutic",
        "inc",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "protagonist",
        "therapeutic",
        "inc",
        "qtrly",
        "license",
        "collaboration",
        "revenue",
        "related",
        "party",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}